Fibromyalgia is a common chronic condition that is estimated to affect approximately 1 in every 25 individuals globally (being 4% of the population). Although men may be affected by this condition, women are ten times more likely to develop it.

ProleevaMax attends to the resolution of the disorder with a formulation addressing the multitude of issues faced with fibromyalgia. In specific terms, ProleevaMax is formulated to respond to the neurosensory disorder by handling the plurality of biological variables.

Rheumatoid arthritis is a chronic inflammatory disorder that affects more than just your joints. Normally, your immune system helps protect your body from infection and disease, however, with rheumatoid arthritis, your immune system attacks healthy tissue in your body.

Rheumatoid arthritis affects the lining of your joints, causing a painful swelling (inflammation) that can eventually result in bone erosion and joint deformity. This chronic disease can also cause other medical problems with your heart, lungs, nerves, eyes, and skin.

ProleevaMax Nutraceutical is effective with rheumatoid arthritis (RA) because it targets the production of “trigger molecules,” the inflammatory autoimmune disease that the body systemically produces. ProleevaMax also reduces the inflammatory chemicals endotoxins, leucocytes, neutrophils, basophils, and many more, enabling the reduction of inflammation and associated pain.

Osteoporosis is a chronic disorder where your bones become weak and brittle. Under normal circumstances, the body constantly absorbs and replaces bone tissue; however, when dealing with osteoporosis, the formation of new bone can’t keep up with the removal of old bone. This results in inflammation and more bone loss than bone rebuilding, making the bones very brittle and weak.

While existing treatments & medications to manage osteoporosis exist and are good, they do not attend to the increased pro-inflammatory proteins. The body continues to produce inflammatory proteins, causing the treatments to potentially be less effective, or the disease not improving.

Inflammatory disease can increase bone breakdown or decrease bone formation, and most commonly impacts both processes resulting in an unfavorable result of more bone loss than bone formation. ProleevaMax attends to the reduction of pro-inflammatory proteins, enabling the remodeling process of bone loss to be more effective.

Gout is the most common inflammatory type of arthritis in adults. It is a disorder of uric acid metabolism by the kidneys that results in deposits of monosodium urate crystals in the joints and nearby connective tissues. The deposition of crystals causes local inflammatory swelling that is extremely painful. Gout occurs when urate crystals accumulate in your joint, causing inflammation and intense pain of a gout attack.

The anti-inflammatory properties of ProleevaMax attend to the treatment of gout. In multiple clinical trials, it has been noted that the ingredients in ProleevaMax improved pain and severity of inflammation in patients with gout and allowed for more effective control of gout inflammation and pain.